Variant report
Variant | nsv1006448 |
---|---|
Chromosome Location | chr1:189835520-189880523 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:75)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr1:189869294-189869344 | K562 | blood: | n/a | n/a |
2 | ATF1 | chr1:189849426-189849494 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr1:189864066-189864360 | HepG2 | liver: | n/a | chr1:189864217-189864230 chr1:189864219-189864228 chr1:189864217-189864228 chr1:189864219-189864228 chr1:189864219-189864228 chr1:189864218-189864229 chr1:189864219-189864228 |
4 | CEBPB | chr1:189837043-189837350 | A549 | lung: | n/a | n/a |
5 | CEBPB | chr1:189864108-189864385 | IMR90 | lung: | n/a | chr1:189864217-189864230 chr1:189864219-189864228 chr1:189864217-189864228 chr1:189864219-189864228 chr1:189864219-189864228 chr1:189864218-189864229 chr1:189864219-189864228 |
6 | CHD1 | chr1:189867799-189867825 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | CTCF | chr1:189867531-189867571 | Kidney_OC | kidney: | n/a | n/a |
8 | CTCF | chr1:189845480-189845630 | GM12872 | blood: | n/a | n/a |
9 | CUX1 | chr1:189862299-189862379 | GM12878 | blood: | n/a | n/a |
10 | E2F4 | chr1:189860844-189860979 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | EP300 | chr1:189849056-189849988 | SK-N-SH | brain: | n/a | n/a |
12 | EP300 | chr1:189849288-189849583 | SK-N-SH_RA | brain: | n/a | n/a |
13 | EP300 | chr1:189849300-189849593 | SK-N-SH_RA | brain: | n/a | n/a |
14 | ESR1 | chr1:189852112-189852468 | ECC-1 | luminal epithelium: | n/a | n/a |
15 | ESR1 | chr1:189852207-189852492 | ECC-1 | luminal epithelium: | n/a | n/a |
16 | FOS | chr1:189843012-189843091 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | FOXA2 | chr1:189838530-189838813 | A549 | lung: | n/a | n/a |
18 | GATA2 | chr1:189849212-189849890 | SH-SY5Y | brain: | n/a | n/a |
19 | GATA3 | chr1:189860873-189860897 | SH-SY5Y | brain: | n/a | n/a |
20 | GATA3 | chr1:189855011-189855427 | SH-SY5Y | brain: | n/a | chr1:189855250-189855271 chr1:189855257-189855264 chr1:189855257-189855264 chr1:189855257-189855264 |
21 | GATA3 | chr1:189846984-189847039 | SH-SY5Y | brain: | n/a | n/a |
22 | GATA3 | chr1:189849154-189849914 | SK-N-SH | brain: | n/a | n/a |
23 | GATA3 | chr1:189849146-189849886 | SH-SY5Y | brain: | n/a | n/a |
24 | GATA3 | chr1:189849213-189849838 | SK-N-SH | brain: | n/a | n/a |
25 | JUN | chr1:189863367-189863468 | K562 | blood: | n/a | n/a |
26 | JUND | chr1:189860639-189860927 | HepG2 | liver: | n/a | chr1:189860829-189860838 |
27 | KAP1 | chr1:189857690-189858077 | K562 | blood: | n/a | n/a |
28 | MAFF | chr1:189843875-189844190 | HepG2 | liver: | n/a | chr1:189844027-189844045 |
29 | MAFF | chr1:189877261-189877565 | K562 | blood: | n/a | n/a |
30 | MAFF | chr1:189873780-189873880 | K562 | blood: | n/a | n/a |
31 | MAFF | chr1:189843938-189844138 | K562 | blood: | n/a | chr1:189844027-189844045 |
32 | MAFF | chr1:189877274-189877610 | HepG2 | liver: | n/a | n/a |
33 | MAFF | chr1:189873697-189874000 | HepG2 | liver: | n/a | n/a |
34 | MAFK | chr1:189844009-189844059 | K562 | blood: | n/a | chr1:189844029-189844044 |
35 | MAFK | chr1:189846527-189846689 | HepG2 | liver: | n/a | chr1:189846624-189846639 |
36 | MAFK | chr1:189843863-189844216 | HepG2 | liver: | n/a | chr1:189844029-189844044 |
37 | MAFK | chr1:189873733-189873977 | HepG2 | liver: | n/a | n/a |
38 | MAFK | chr1:189843900-189844198 | HepG2 | liver: | n/a | chr1:189844029-189844044 |
39 | MAFK | chr1:189873669-189874012 | HepG2 | liver: | n/a | n/a |
40 | MAFK | chr1:189873817-189873937 | Hela-S3 | cervix: | n/a | n/a |
41 | MAFK | chr1:189842993-189843263 | HepG2 | liver: | n/a | n/a |
42 | MAFK | chr1:189846511-189846761 | HepG2 | liver: | n/a | chr1:189846624-189846639 |
43 | MAFK | chr1:189843861-189844222 | IMR90 | lung: | n/a | chr1:189844029-189844044 |
44 | MAFK | chr1:189842959-189843287 | HepG2 | liver: | n/a | n/a |
45 | MAFK | chr1:189877265-189877634 | HepG2 | liver: | n/a | chr1:189877436-189877450 chr1:189877438-189877449 chr1:189877437-189877448 |
46 | MAFK | chr1:189873689-189874002 | IMR90 | lung: | n/a | n/a |
47 | MAFK | chr1:189842153-189842373 | HepG2 | liver: | n/a | n/a |
48 | MAFK | chr1:189877250-189877621 | IMR90 | lung: | n/a | chr1:189877436-189877450 chr1:189877438-189877449 chr1:189877437-189877448 |
49 | MAFK | chr1:189877343-189877508 | H1-hESC | embryonic stem cell: | n/a | chr1:189877436-189877450 chr1:189877438-189877449 chr1:189877437-189877448 |
50 | MAFK | chr1:189877252-189877572 | Hela-S3 | cervix: | n/a | chr1:189877436-189877450 chr1:189877438-189877449 chr1:189877437-189877448 |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:189844299..189845892-chr1:189850457..189852405,2 | MCF-7 | breast: | |
2 | chr1:189117678..189120245-chr1:189847842..189850269,2 | K562 | blood: | |
3 | chr1:189853792..189857239-chr1:189857756..189861653,3 | MCF-7 | breast: | |
4 | chr1:189844299..189845892-chr1:189850457..189852405,2 | MCF-7 | breast: | |
5 | chr1:189813747..189815721-chr1:189850350..189852733,2 | K562 | blood: | |
6 | chr1:189853792..189857239-chr1:189857756..189861653,3 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM5C-1 | chr1:189837131-189837342 | XLOC_001130 |
2 | lnc-FAM5C-1 | chr1:189837457-189837658 | XLOC_001130 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000238270 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs76409883 | chr1:189837138-189837139 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs192172254 | chr1:189837270-189837271 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs539430908 | chr1:189837296-189837297 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs140367905 | chr1:189837311-189837312 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs576639672 | chr1:189837322-189837323 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs542533090 | chr1:189837360-189837361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562108283 | chr1:189837363-189837364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs2292762 | chr1:189837364-189837365 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs541081582 | chr1:189837374-189837375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564239928 | chr1:189837400-189837401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs184566649 | chr1:189837430-189837431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs149466366 | chr1:189837476-189837477 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs549751365 | chr1:189837527-189837528 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs563360673 | chr1:189837531-189837532 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs531468779 | chr1:189837595-189837596 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs189430616 | chr1:189837612-189837613 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs55845245 | chr1:189837640-189837641 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs2944690 | chr1:189837652-189837653 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs547652341 | chr1:189837653-189837654 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs6697981 | chr1:189837770-189837771 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs149884792 | chr1:189837772-189837773 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs189113727 | chr1:189838539-189838540 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs551013062 | chr1:189838583-189838584 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs557894233 | chr1:189838630-189838631 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs577823736 | chr1:189838636-189838637 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs543462768 | chr1:189838740-189838741 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs557999029 | chr1:189838747-189838748 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs557423578 | chr1:189838764-189838765 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs574090404 | chr1:189838770-189838771 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs573239014 | chr1:189838783-189838784 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs534107449 | chr1:189838786-189838787 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs542991622 | chr1:189838790-189838791 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs559515412 | chr1:189838794-189838795 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs527556150 | chr1:189838809-189838810 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs564446977 | chr1:189838810-189838811 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs11805759 | chr1:189839800-189839801 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs571591003 | chr1:189839826-189839827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs3005710 | chr1:189839840-189839841 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs551126064 | chr1:189839877-189839878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368751896 | chr1:189839905-189839906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs370536147 | chr1:189839943-189839944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190193281 | chr1:189839953-189839954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553195318 | chr1:189839983-189839984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577169186 | chr1:189840069-189840070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529085671 | chr1:189840083-189840084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533894612 | chr1:189840085-189840086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs3005711 | chr1:189840086-189840087 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs67606262 | chr1:189840105-189840106 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs75195188 | chr1:189840109-189840110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577985769 | chr1:189840129-189840130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17899364 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:189837200-189837600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr1:189839800-189841000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr1:189840000-189841000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr1:189840000-189841200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr1:189840400-189840600 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr1:189844400-189845000 | Enhancers | Fetal Heart | heart |
7 | chr1:189868000-189870800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr1:189868200-189868400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr1:189868200-189869600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr1:189868200-189870000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr1:189868400-189870000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr1:189868600-189869200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr1:189868600-189870000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr1:189868800-189869600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
15 | chr1:189868800-189869600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
16 | chr1:189868800-189870000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr1:189869000-189869600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
18 | chr1:189869200-189869600 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
19 | chr1:189869200-189869600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
20 | chr1:189869400-189869800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
21 | chr1:189869600-189870200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
22 | chr1:189869800-189884200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
23 | chr1:189870200-189870600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
24 | chr1:189870600-189871000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
25 | chr1:189870800-189871000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
26 | chr1:189876800-189877000 | Enhancers | Spleen | Spleen |